In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53
- 1 September 1993
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 23 (9), 2072-2077
- https://doi.org/10.1002/eji.1830230905
Abstract
The central role of the p53 tumor suppressor gene product in oncogenesis is gradually being clarified. Point mutations in the p53 tumor suppressor gene are common in most human cancers and are often associated with p53 protein overexpression. Overexpressed wild‐type or mutant determinants of the p53 protein thus represent an attractive target for immunotherapy of cancer directed against a structure involved in malignant transformation. An important step towards this goal is identification of epitopes of p53 that can be recognized by human cytotoxic T lymphocytes. We identified peptides of (mutant) p53 capable of binding to HLA‐A2.1 in an in vitro assay. These HLA‐A2.1‐binding peptides were utilized for in vitro induction of primary cytotoxic T lymphocyte responses using a human processing‐defective cell line (174CEM.T2) as antigen‐presenting cell. These cells display “empty” HLA class I surface molecules, that can efficiently be loaded with a single peptide. We obtained CD8+ cytotoxic T lymphocyte clones capable of specifically lysing target cells loaded with wild‐type or tumor‐specific mutant p53 peptides. This strategy allows the in vitro initiation of human cytotoxic T lymphocyte responses against target molecules of choice.Keywords
This publication has 54 references indexed in Scilit:
- In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptidesEuropean Journal of Immunology, 1992
- Mechanisms of induction of primary virus‐specific cytotoxic T lymphocyte responsesEuropean Journal of Immunology, 1992
- Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I moleculesNature, 1992
- In a small multideterminant peptide, each determinant is recognized by a different V beta gene segment.The Journal of Experimental Medicine, 1992
- T-cell responses against products of oncogenes: Generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptidesHuman Immunology, 1992
- Autologous Tumor-Specific Cytotoxicity of Tumor-Infiltrating Lymphocytes Derived from Human Renal Cell CarcinomaJournal of Immunotherapy, 1991
- The dominant self and the cryptic self: shaping the autoreactive T-cell repertoireImmunology Today, 1991
- The p53 tumour suppressor geneNature, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Antigen recognition by H‐2‐restricted cytolytic T lymphocytes: inhibition of cytolysis by anti‐CDS monoclonal antibodies depends upon both concentration and primary sequence of peptide antigenEuropean Journal of Immunology, 1988